- Patent Title: Compounds for inhibiting cell proliferation in EGFR-driven cancers
-
Application No.: US15044382Application Date: 2016-02-16
-
Publication No.: US09834571B2Publication Date: 2017-12-05
- Inventor: Xiaotian Zhu , Yihan Wang , William C. Shakespeare , Wei-Sheng Huang , David C. Dalgarno
- Applicant: ARIAD Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Proskauer Rose LLP
- Agent Fangli Chen
- Main IPC: C07D239/46
- IPC: C07D239/46 ; C07D239/50 ; C07D401/12 ; C07D403/12 ; C07D413/12 ; C07D265/36 ; A61K31/506 ; A61K31/4025 ; A61K31/444 ; A61K31/4523 ; A61K31/538 ; A61K31/553 ; C07F9/6512 ; C07D239/48 ; C07F9/6521 ; C07F9/6558 ; C07F9/6561 ; C07F9/6584 ; A61K31/505 ; A61K31/675 ; A61K45/06 ; C07F9/28 ; C07D239/42 ; A61K35/00
Abstract:
The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of Formula I: wherein the variables are as defined herein.
Public/Granted literature
- US20160244469A1 Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers Public/Granted day:2016-08-25
Information query
